Paper24176554
Escaping the immune system: How the malaria parasite makes vaccine development a challenge.
Stanisic DI and 2 others. Trends Parasitol, 2013. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Escaping the immune system: How the malaria parasite makes vaccine development a challenge. Papers, record 24176554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24176554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Escaping the immune system: How the malaria parasite makes vaccine development a challenge.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Host-Parasite Interactions | Major topic |
| Immune System | Major topic |
| Malaria | Major topic |
| Malaria Vaccines | Major topic |
| Animals | |
| Humans | |
| Plasmodium |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41208999 | Micro-geographic variation in antigenic diversity of PfEBA-175 region II in asymptomatic Plasmodium falciparum infections in Tanzania. | Front Immunol | 2025 | https://conductscience.org/library/papers/41208999 | PubMed |
| 41128014 | Extreme Genetic Diversity and Signatures of Balancing Selection in Plasmodium vivax Blood-Stage Antigens. | J Infect Dis | 2026 | https://conductscience.org/library/papers/41128014 | PubMed |
| 39759387 | Genetic diversity of Plasmodium vivax and Plasmodium falciparum field isolates from Honduras in the malaria elimination phase. | Curr Res Parasitol Vector Borne Dis | 2025 | https://conductscience.org/library/papers/39759387 | PubMed |
| 37728713 | Malaria Vaccines: Progress to Date. | BioDrugs | 2023 | https://conductscience.org/library/papers/37728713 | PubMed |
| 37684152 | Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine. | Trends Parasitol | 2023 | https://conductscience.org/library/papers/37684152 | PubMed |
| 37396303 | A conserved epitope in VAR2CSA is targeted by a cross-reactive antibody originating from Plasmodium vivax Duffy binding protein. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37396303 | PubMed |
| 36685595 | Host-parasite interactions during Plasmodium infection: Implications for immunotherapies. | Front Immunol | 2022 | https://conductscience.org/library/papers/36685595 | PubMed |
| 35349608 | Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates. | PLoS One | 2022 | https://conductscience.org/library/papers/35349608 | PubMed |
| 35108259 | Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/35108259 | PubMed |
| 34987497 | Plasmodium berghei-Released Factor, PbTIP, Modulates the Host Innate Immune Responses. | Front Immunol | 2021 | https://conductscience.org/library/papers/34987497 | PubMed |
| 32174924 | The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design. | Front Immunol | 2020 | https://conductscience.org/library/papers/32174924 | PubMed |
| 32133407 | Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. | Sci Adv | 2020 | https://conductscience.org/library/papers/32133407 | PubMed |
| 30538708 | Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection. | Front Immunol | 2018 | https://conductscience.org/library/papers/30538708 | PubMed |
| 30479379 | Models of immune selection for multi-locus antigenic diversity of pathogens. | Nat Rev Immunol | 2019 | https://conductscience.org/library/papers/30479379 | PubMed |
| 30239833 | Plasmodium falciparum Activates CD16+ Dendritic Cells to Produce Tumor Necrosis Factor and Interleukin-10 in Subpatent Malaria. | J Infect Dis | 2019 | https://conductscience.org/library/papers/30239833 | PubMed |
| 29765991 | Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites. | J Immunol Res | 2018 | https://conductscience.org/library/papers/29765991 | PubMed |
| 29376476 | A bite to fight: front-line innate immune defenses against malaria parasites. | Pathog Glob Health | 2018 | https://conductscience.org/library/papers/29376476 | PubMed |
| 29162686 | Atypical activation of dendritic cells by Plasmodium falciparum. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29162686 | PubMed |
| 28161402 | The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates. | Int J Parasitol | 2017 | https://conductscience.org/library/papers/28161402 | PubMed |
| 27604988 | Characterization of fine specificity of the immune response to a Plasmodium falciparum rhoptry neck protein, PfAARP. | Malar J | 2016 | https://conductscience.org/library/papers/27604988 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24176554
GET https://conductscience.org/api/papers/v1/24176554/cited_by?page=2